Intravascular Imaging of Lipid Core Plaque by Near-Infrared Spectroscopy

Intravascular Imaging of Lipid Core Plaque by Near-Infrared Spectroscopy

Emmanouil S. Brilakis, Stephen T. Sum, Sean P. Madden, James E. Muller
ISBN13: 9781613500958|ISBN10: 1613500955|EISBN13: 9781613500965
DOI: 10.4018/978-1-61350-095-8.ch014
Cite Chapter Cite Chapter

MLA

Brilakis, Emmanouil S., et al. "Intravascular Imaging of Lipid Core Plaque by Near-Infrared Spectroscopy." Intravascular Imaging: Current Applications and Research Developments, edited by Vasilios D. Tsakanikas, et al., IGI Global, 2012, pp. 240-259. https://doi.org/10.4018/978-1-61350-095-8.ch014

APA

Brilakis, E. S., Sum, S. T., Madden, S. P., & Muller, J. E. (2012). Intravascular Imaging of Lipid Core Plaque by Near-Infrared Spectroscopy. In V. Tsakanikas, L. Michalis, D. Fotiadis, K. Naka, & C. Bourantas (Eds.), Intravascular Imaging: Current Applications and Research Developments (pp. 240-259). IGI Global. https://doi.org/10.4018/978-1-61350-095-8.ch014

Chicago

Brilakis, Emmanouil S., et al. "Intravascular Imaging of Lipid Core Plaque by Near-Infrared Spectroscopy." In Intravascular Imaging: Current Applications and Research Developments, edited by Vasilios D. Tsakanikas, et al., 240-259. Hershey, PA: IGI Global, 2012. https://doi.org/10.4018/978-1-61350-095-8.ch014

Export Reference

Mendeley
Favorite

Abstract

Intracoronary near-infrared spectroscopy (NIRS) is a novel catheter-based technique that allows determination of the chemical composition of the coronary artery wall. This is accomplished by measuring the proportion of near-infrared light diffusely reflected by the arterial wall after scattering and absorption have occurred. Histology and clinical studies have validated that NIRS can detect with high accuracy the presence of coronary lipid core plaques, which form the substrate for most acute coronary syndromes and complicate stenting procedures. Coronary NIRS is currently being evaluated as a tool to: (Clarke, Figg, & Maguire, 2006) optimize the outcomes of percutaneous coronary interventions (PCI), (Ross, 1999) identify coronary lesions at risk for causing events and optimize the medical management of such patients, and (Kagan, Livsic, Sternby, & Vihert, 1968) allow evaluation of novel anti-atherosclerotic treatments.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.